International Society on Thrombosis and Haemostasis, Inc.
Lunch Symposia
Enter Registration Site

Monday, June 22, 2015

Room: 718

Download Program Flyer
30 years of research with rFVIIa (eptacog alfa activated): modern patient care with an established treatment option

Novo Nordisk

Moderators: Ulla Hedner (Sweden) and Victor Blanchette (Canada)

Lecture Time Lecture Title Speaker
12:15 - 12:20 Welcome  
12:20 - 12:35 30 years of research with rFVIIa (eptacog alfa activated): a breakthrough in science changing lives for haemophilia patients with inhibitors Ulla Hedner (Sweden)
12:35 - 12:50 An ongoing journey: efficacy and safety profile of rFVIIa (eptacog alfa activated) Ellis Neufeld (United States)
12:50 - 13:05 Preserving joint and musculoskeletal health: optimisng outcomes Victor Blanchette (Canada)
13:05 - 13:20 Acquired haemophilia: importance of early diagnosis and safe and effective treatment Andreas Tiede (Germany)
13:20 - 13:35 A total commitment to patient care: rFVIIa (eptacog alfa activated) for women with rare bleeding disorders Roseline D’Oiron (France)
13:35 - 13:45 Close  

All Corporate Symposia ISTH 2015 Daily Schedule
 Key Dates

March 11, 2015
Early Registration Deadline

June 15, 2015
Online Registration Deadline

June 20-25, 2015
ISTH 2015